Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 503
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
for
Cutaneous Melanoma
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT03842943
Phase 2, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Louisville KY, Toronto, Orlando FL, Portland OR
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06282575
Phase 3, Recruiting
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
for
Carcinoma, Hepatocellular, Cirrhosis
Location: Louisville KY, St Louis MO, Ann Arbor MI, Cleveland OH,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT05486572
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Location: Louisville KY, Nashville TN, Hines IL, Ann Arbor MI,
Sponsor: VA Office of Research and Development
Sex: All
Age: 60+
Code: NCT05996328
Recruiting
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
for
Metastatic Prostate Cancer
Location: Louisville KY, Nashville TN, St Louis MO, Decatur GA,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05011383
Phase 2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Louisville KY, Nashville TN, St Louis MO, Niles IL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Louisville KY, Nashville TN, Atlanta GA, Cleveland OH,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05536141
Phase 1, Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects
for
Cystic Fibrosis
Location: Louisville KY, Columbus OH, Chicago IL, Cleveland OH,
Sponsor: Aridis Pharmaceuticals, Inc.
Sex: All
Age: 18 - 49
Code: NCT03669614
Phase 1, Phase 2, Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
for
Asthma
Location: Louisville KY, Noblesville IN, Toledo OH,